Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9CYC6

Entry ID Method Resolution Chain Position Source
AF-Q9CYC6-F1 Predicted AlphaFoldDB

21 variants for Q9CYC6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389479166 26 S>R No EVA
rs3389501712 38 Q>H No EVA
rs3389502979 58 P>L No EVA
rs3411602252 80 G>D No EVA
rs3389494925 84 E>D No EVA
rs3408121096 120 A>G No EVA
rs3408399200 121 K>E No EVA
rs3389501715 150 G>V No EVA
rs3389459085 184 T>S No EVA
rs3408121093 191 R>I No EVA
rs3389494894 191 R>S No EVA
rs3389468598 201 S>A No EVA
rs3389468567 245 D>E No EVA
rs30220684 300 S>P No EVA
rs3408499233 345 K>Q No EVA
rs3408473713 347 Q>H No EVA
rs3408499114 348 N>K No EVA
rs3408427519 349 P>L No EVA
rs3389494907 353 C>R No EVA
rs3389510012 392 A>V No EVA
rs266140979 405 A>T No EVA

No associated diseases with Q9CYC6

5 regional properties for Q9CYC6

Type Name Position InterPro Accession
domain Tyrosine-specific protein phosphatases domain 344 - 406 IPR000387
domain Protein-tyrosine phosphatase, catalytic 323 - 471 IPR003595
domain GRAM domain 29 - 143 IPR004182
domain Myotubularin-like, phosphatase domain 151 - 538 IPR010569
active_site Protein-tyrosine phosphatase, active site 373 - 383 IPR016130

Functions

Description
EC Number 3.6.1.62 In phosphorus-containing anhydrides
Subcellular Localization
  • Cytoplasm, P-body
  • Nucleus
  • Predominantly cytoplasmic, in processing bodies (PB) (By similarity)
  • A minor amount is nuclear (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cell junction A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic ribonucleoprotein granule A ribonucleoprotein granule located in the cytoplasm.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
P-body A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing.
RISC complex A ribonucleoprotein complex that contains members of the Argonaute family of proteins, small interfering RNAs (siRNAs) or microRNAs (miRNAs), and miRNA or siRNA-complementary mRNAs, in addition to a number of accessory factors. The RISC complex is involved in posttranscriptional repression of gene expression through downregulation of translation or induction of mRNA degradation.

4 GO annotations of molecular function

Name Definition
5'-3' exoribonuclease activity Catalysis of the sequential cleavage of mononucleotides from a free 5' terminus of an RNA molecule.
m7G(5')pppN diphosphatase activity Catalysis of the reaction: 7-methylguanosine 5'-triphospho-5'-polynucleotide + H2O = 7-methylguanosine 5'-phosphate + polynucleotide.
manganese ion binding Binding to a manganese ion (Mn).
RNA binding Binding to an RNA molecule or a portion thereof.

7 GO annotations of biological process

Name Definition
deadenylation-dependent decapping of nuclear-transcribed mRNA Cleavage of the 5'-cap of a nuclear mRNA triggered by shortening of the poly(A) tail to below a minimum functional length.
histone mRNA catabolic process The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA).
mRNA catabolic process The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes.
negative regulation of telomere maintenance via telomerase Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of telomeric repeats by telomerase.
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
regulation of mRNA stability Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs.
regulation of telomerase RNA localization to Cajal body Any process that modulates the frequency, rate or extent of telomerase RNA localization to Cajal body.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MEPKRLEIPG SVLDDLCSRF ILHIPSEERD NAIRVCFQIE LAHWFYLDFY MQNTPGLPQC
70 80 90 100 110 120
GIRDFAKAVF SHCPFLLPQG EDVEKILDEW KEYKMGVPTY GAIILDETLE NVLLVQGYLA
130 140 150 160 170 180
KSGWGFPKGK VNKEEAPHDC AAREVFEETG FDIKDYICKD DYIELRINDQ LARLYIIPGV
190 200 210 220 230 240
PKDTKFNPKT RREIRNIEWF SIEKLPCHRN DMTPKSKLGL APNKFFMAIP FIRPLRDWLS
250 260 270 280 290 300
RRFGDSSDSD NGFSSAGSTP ARPTVEKLSR TKFRHSQQLF PEGSPSDQWV KHRQPLQQKS
310 320 330 340 350 360
HSNHGEVSDL LKAKNQNMRG NGRKQYQDSP NQKKRANGVH GQPAKQQNPL VKCEKKLHPR
370 380 390 400 410 420
KLQDNFETDA TCDLPCSGEE PSVEHAEGHS VACNGHCKFP FSSRAFLSFK FDQNAIMKIL
DL